News
05-Aug-2008 - AGOWA genomics adds the Roche GS FLX
system to its sequencing portfolio
AGOWA genomics has added a
Genome Sequencer FLX System from Roche to its technology
portfolio.
The acquisition of the Roche GS FLX enables
AGOWA genomics to meet the growing market demands for higher
capacity and higher throughput.
AGOWA genomics’ customers can now take
advantage of the company’s increased sequencing capacity and the
expanded range of applications and services, such as:
- De novo sequencing of prokaryotic
and small eukaryotic genomes
- Completion of de novo sequencing including
resolution of repeats and gap closure applying a combination of 454
and Sanger sequencing
- Analysis of metagenomes, transcriptomes /
normalised cDNA, methylation patterns, pools of tagged fosmids and
BACs
- Targeted re-sequencing (amplicons and
genotyping).
Furthermore, AGOWA genomics is one of the
first sites to apply the novel GS FLX TITANIUM series of reagents
that Roche will launch in autumn 2008. The benefit of the TITANIUM
series is the significantly longer read length over the GS FLX
standard series with a Q20 read length of over 400 bases, and a
total of up to 500 million bases per instrument run.
AGOWA genomics will install an additional,
powerful off-rig server at its laboratory in Berlin, Germany. This
will fulfil the computational requirements of the increased
throughput as well as keep processing time short - and consequently
help deliver a fast turnaround of ultra-high-throughput sequencing
results.
With these new capabilities in
ultra-high-throughput sequencing, staff from AGOWA genomics will
work in collaboration with their fellow scientists in LGC’s
corporate Research & Technology Division, to elucidate a number
of challenging scientific themes.
This work will help to establish new
applications in the near future. For the operation of the new
technology, AGOWA genomics will enlarge its sequencing labs and
employ additional sequencing specialists and lab staff.
Dr. Wolfgang Zimmermann – AGOWA genomics’
Business Unit Manager Sequencing, stated: “The acquisition of
the GS FLX will considerably extend our service portfolio and will
strengthen our reputation as a high-end sequencing services
provider.”
Please visit the common AGOWA
genomics and LGC Standards stand at
BioTechnica 2008
in Hall 9 at Booth F51.
About AGOWA
genomics
AGOWA GmbH is an international acting
genomics company. The company was established in 1993 and has been
part of LGC since December 2005 - under the brand AGOWA
genomics (www.lgc.co.uk/genomics).
The portfolio of products and services
comprises:
- Nucleic acid preparation – products and
services
- DNA sequencing services
- Genomic services.
Notes to Editors